• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多形性腺瘤和复发性多形性腺瘤恶变的比较纵向分析

Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma.

作者信息

Choi Sung Yong, Choi Jaehyuck, Hwang Inwoo, Cho Junhun, Ko Young-Hyeh, Jeong Han-Sin

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Department of Otorhinolaryngology-Head and Neck Surgery, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Daejeon 34824, Korea.

出版信息

J Clin Med. 2022 Mar 25;11(7):1808. doi: 10.3390/jcm11071808.

DOI:10.3390/jcm11071808
PMID:35407417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8999507/
Abstract

Background: Recurrence in pleomorphic adenoma (PA) has been debated as a risk factor for malignant transformation (MT). In this study, we investigated whether recurrence is a risk factor for MT, by longitudinally analyzing cases with recurrent PA (RPA), and carcinomas from PA (CXPA) or RPA (CXRPA). Methods: The study population included 24 CXPA, 24 RPA, 6 CXRPA, and 386 PA cases (study period 2010−2018). Time and event data were collected from the medical documents to identify the time−event sequences. Results: The time interval to MT in CXRPA was significant longer than that of benign recurrence (median 342.0 vs. 109.5 months). In CXRPA, the recurrence intervals were not shorter than those in RPA according to recurrence frequency. Crudely, the MT rate was 5.9% among primary cases and 20.0% among recurrent cases. However, the time-adjusted MT rates increased up to 11.4% (incubation time > 60 months) and 20.0% (>120 months) in primary cases, which were not different from recurrent cases. Conclusion: In these longitudinal analyses, we did not find any clinical evidence that recurrence facilitates MT in the background of PA. Instead, a long incubation time seems to be a key factor for MT of underlying RPA.

摘要

背景

多形性腺瘤(PA)的复发一直被认为是恶性转化(MT)的一个危险因素。在本研究中,我们通过纵向分析复发性PA(RPA)、PA来源的癌(CXPA)或RPA来源的癌(CXRPA)病例,研究复发是否为MT的危险因素。方法:研究人群包括24例CXPA、24例RPA、6例CXRPA和386例PA病例(研究时间段为2010 - 2018年)。从医疗文档中收集时间和事件数据,以确定时间 - 事件序列。结果:CXRPA发生MT的时间间隔显著长于良性复发(中位数分别为342.0个月和109.5个月)。在CXRPA中,根据复发频率,复发间隔并不短于RPA中的复发间隔。粗略计算,原发病例的MT率为5.9%,复发病例为20.0%。然而,经时间调整后的原发病例MT率在潜伏期>60个月时升至11.4%,>120个月时升至20.0%,与复发病例无差异。结论:在这些纵向分析中,我们未发现任何临床证据表明在PA背景下复发会促进MT。相反,较长的潜伏期似乎是潜在RPA发生MT的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9ea/8999507/6822ae7ac4fa/jcm-11-01808-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9ea/8999507/1f86079b0e51/jcm-11-01808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9ea/8999507/4faf7773fce3/jcm-11-01808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9ea/8999507/6822ae7ac4fa/jcm-11-01808-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9ea/8999507/1f86079b0e51/jcm-11-01808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9ea/8999507/4faf7773fce3/jcm-11-01808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9ea/8999507/6822ae7ac4fa/jcm-11-01808-g003.jpg

相似文献

1
Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma.多形性腺瘤和复发性多形性腺瘤恶变的比较纵向分析
J Clin Med. 2022 Mar 25;11(7):1808. doi: 10.3390/jcm11071808.
2
Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.与未发生恶变的复发性多形性腺瘤相比,源自复发性多形性腺瘤的癌在比较基因组杂交阵列分析中显示出重要差异。
Braz J Otorhinolaryngol. 2016 Nov-Dec;82(6):687-694. doi: 10.1016/j.bjorl.2015.12.004. Epub 2016 Feb 24.
3
Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.涎腺复发性多形性腺瘤中Rb信号通路的失调
Virchows Arch. 2015 Sep;467(3):295-301. doi: 10.1007/s00428-015-1804-x. Epub 2015 Jul 9.
4
Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.复发性多形性腺瘤中雌激素受体、孕激素受体及HER-2的表达
Clin Pathol. 2019 Sep 26;12:2632010X19873384. doi: 10.1177/2632010X19873384. eCollection 2019 Jan-Dec.
5
Clinical manifestations of recurrent parotid pleomorphic adenoma.复发性腮腺多形性腺瘤的临床表现。
Clin Exp Otorhinolaryngol. 2009 Dec;2(4):193-7. doi: 10.3342/ceo.2009.2.4.193. Epub 2009 Dec 31.
6
[Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].[大唾液腺多形性腺瘤癌变——临床病理综述]
Otolaryngol Pol. 2007;61(5):687-93. doi: 10.1016/S0030-6657(07)70507-3.
7
Risk factors for carcinoma ex pleomorphic adenoma in patients presenting with recurrence after resection of pleomorphic adenoma.复发性多形性腺瘤切除术后复发患者的癌在多形性腺瘤中风险因素。
Head Neck. 2021 Feb;43(2):419-427. doi: 10.1002/hed.26489. Epub 2020 Oct 12.
8
Increase in Chymase-Positive Mast Cells in Recurrent Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland.腮腺富细胞型多形性腺瘤和癌在多形性腺瘤复发中的类糜蛋白酶阳性肥大细胞增加。
Int J Mol Sci. 2021 Nov 23;22(23):12613. doi: 10.3390/ijms222312613.
9
Increased MIB-1 expression in salivary gland pleomorphic adenoma that recurs and undergoes malignant transformation.在复发性和发生恶性转化的涎腺多形性腺瘤中,MIB-1 表达增加。
Sci Rep. 2022 May 30;12(1):9029. doi: 10.1038/s41598-022-13082-8.
10
The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.在唾液腺多形性腺瘤复发中,PDGF-A、PDGF-B 和 FGF-2 的表达增加。
J Clin Pathol. 2012 Mar;65(3):272-7. doi: 10.1136/jclinpath-2011-200405. Epub 2011 Dec 15.

引用本文的文献

1
Clinical features and prognosis of carcinoma ex pleomorphic adenoma of the lacrimal gland: a comprehensive case series and literature review.泪腺多形性腺瘤癌变的临床特征与预后:一项综合病例系列研究及文献综述
Int J Ophthalmol. 2025 Sep 18;18(9):1650-1657. doi: 10.18240/ijo.2025.09.05. eCollection 2025.
2
Novel Detection of Pleomorphic Adenomas via Analysis of Ga-DOTATOC PET/CT Imaging.通过分析镓- DOTATOC PET/CT成像对多形性腺瘤进行新型检测
Cancers (Basel). 2024 Jul 23;16(15):2624. doi: 10.3390/cancers16152624.
3
Long-term follow-up of tracheal pleomorphic adenoma: A case report.

本文引用的文献

1
Natural history of recurrent pleomorphic adenoma: implications on management.复发性多形性腺瘤的自然病史:对治疗的启示。
Head Neck. 2020 Aug;42(8):2058-2066. doi: 10.1002/hed.26137. Epub 2020 Mar 18.
2
Dedifferentiated adenoid cystic carcinoma ex pleomorphic adenoma of the parotid.腮腺多形性腺瘤恶变的去分化腺样囊性癌。
J Cancer Res Ther. 2018 Apr-Jun;14(3):706-708. doi: 10.4103/0973-1482.179522.
3
The recurrent pleomorphic adenoma conundrum.复发性多形性腺瘤难题
气管多形性腺瘤的长期随访:一例报告
Respir Med Case Rep. 2024 Jun 22;51:102073. doi: 10.1016/j.rmcr.2024.102073. eCollection 2024.
4
Clinical behavior of recurrent pleomorphic adenoma in the palate: a systematic review.复发性腭部多形性腺瘤的临床行为:系统评价。
Acta Cir Bras. 2024 Feb 26;39:e390824. doi: 10.1590/acb390824. eCollection 2024.
5
An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers.唾液腺肿瘤类器官文库揭示了肿瘤亚型特异性特征和生物标志物。
J Exp Clin Cancer Res. 2022 Dec 17;41(1):350. doi: 10.1186/s13046-022-02561-5.
6
Lip pleomorphic adenomas: case series and literature review.唇部多形性腺瘤:病例系列及文献综述。
Gland Surg. 2022 Oct;11(10):1730-1740. doi: 10.21037/gs-22-308.
Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):134-141. doi: 10.1097/MOO.0000000000000435.
4
Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.腮腺多形性腺瘤为何会复发?病理及手术相关变量的系统评价
Front Surg. 2017 May 15;4:26. doi: 10.3389/fsurg.2017.00026. eCollection 2017.
5
Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence.荷兰唾液腺多形性腺瘤:一项关于原发性肿瘤发病率、恶变、复发及复发危险因素的全国性观察性研究。
Oral Oncol. 2017 Mar;66:93-99. doi: 10.1016/j.oraloncology.2017.01.004. Epub 2017 Jan 23.
6
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.世界卫生组织头颈部肿瘤分类第4版更新:涎腺肿瘤
Head Neck Pathol. 2017 Mar;11(1):55-67. doi: 10.1007/s12105-017-0795-0. Epub 2017 Feb 28.
7
Invasive myoepithelial carcinoma ex pleomorphic adenoma of the major salivary gland: two case reports.大唾液腺多形性腺瘤恶变侵袭性肌上皮癌:两例报告
BMC Cancer. 2016 Oct 28;16(1):827. doi: 10.1186/s12885-016-2871-3.
8
Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.与未发生恶变的复发性多形性腺瘤相比,源自复发性多形性腺瘤的癌在比较基因组杂交阵列分析中显示出重要差异。
Braz J Otorhinolaryngol. 2016 Nov-Dec;82(6):687-694. doi: 10.1016/j.bjorl.2015.12.004. Epub 2016 Feb 24.
9
Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation.1985 - 2010年腮腺多形性腺瘤:丹麦全国发病率、复发率及恶变情况的研究
Head Neck. 2016 Apr;38 Suppl 1:E1364-9. doi: 10.1002/hed.24228. Epub 2015 Sep 18.
10
Meta-analysis of surgical approaches to the treatment of parotid pleomorphic adenomas and recurrence rates.腮腺多形性腺瘤手术治疗方法及复发率的Meta分析
J Craniomaxillofac Surg. 2015 Jul;43(6):738-45. doi: 10.1016/j.jcms.2015.03.017. Epub 2015 Mar 26.